Moderna has appointed John Sisk as the chosen contractor for its new drug manufacturing unit in Oxfordshire.
- The Institute, known as MITC, is under construction at Harwell Science Campus.
- This state-of-the-art facility will focus on mRNA vaccines production.
- With a budget of £150m, it aims for 250 million vaccines annually.
- Sisk embarks on its first major UK life sciences project.
Moderna has entrusted the construction of its new UK drug manufacturing facility to John Sisk, highlighting an important development in the pharmaceutical landscape. This appointment positions Sisk as the preferred contractor for fitting out the Moderna Innovation & Technology Centre (MITC), poised to become a pivotal site in the UK, located on the esteemed Harwell Science Campus in Oxfordshire.
This cutting-edge MITC seeks to enhance research, development, and production of mRNA vaccines, particularly those responding to covid-19 and other potential respiratory threats. As the world adapts to new health challenges, the facility’s ability to produce up to 250 million vaccines yearly during pandemics marks a significant stride in the UK’s resilience against global health crises.
The scale of the MITC project is underscored by its £150m investment, reflecting a commitment to forward-thinking solutions and technological advancement in the biotech and pharmaceutical sectors. The development is anticipated to become operational by 2025, contingent on the successful acquisition of necessary planning and regulatory approvals.
The project represents John Sisk’s inaugural venture into the UK’s life sciences sector. Donal McCarthy, Sisk’s chief operating officer for life sciences, data & tech, expressed confidence in the team’s ability to deliver exceptional results due to their extensive experience with prominent US clients across Europe. His statement reflects Sisk’s strategic plan to expand its expertise within the UK.
Sisk’s involvement in the MITC marks a significant expansion into the UK life sciences sector, promising robust pandemic readiness.
